Department of Cardiology， 670 Cardiology， Heartcenter， University Medical Center St. Radboud， 10 Geert Grooteplein Zuid， Nijmegen， 6525， The Netherlands， f.verheugt@cardio.umcn.nl.BACKGROUND: Fibrinolytic therapy.....
Chronic Diseases of Lifestyle Unit， Medical Research Council， Tygerberg， South Africa.BACKGROUND: Cardiovascular disease (CVD) is rising in low-income countries. However， the impact of modif.....
Population Health Research Institute， McMaster University-Hamilton Health Sciences， Hamilton， ON L8L 2X2， Canada.BACKGROUND: Tobacco use is one of the major avoidable causes of cardiovasc.....
相关链接：PDF全文 Background A substantial proportion of patients receiving fibrinolytic therapy for myocardial infarction with ST-segment elevation have inadequate reperfusion or reocclusion of the infa.....
Context The benefit of clopidogrel pretreatment before percutaneous coronary intervention (PCI) remains debated and its use has not been universally adopted.Objective: To determine if clopidogrel pretreatment before PCI .....
JAMA. 2005;293:437-446. The CREATE-ECLA Trial Group Investigators Context： Glucose-insulin-potassium (GIK) infusion is a widely applicable， low-cost therapy that has been postulated to improve mortality in patients wit.....
JAMA. 2005;293:427-435. The CREATE Trial Group Investigators Context： Although reperfusion therapy， aspirin， -blockers， and angiotensin-converting enzyme inhibitors reduce mortality when used early in patients with a.....
关注公众号
安卓客户端
